A clinical-stage biopharmaceutical company focused on innovative therapeutic solutions for diabetes and obesity.
About
Adocia is a clinical-stage biotechnology company specializing in the development of innovative treatments for diabetes and obesity. They leverage disruptive technologies to create products ranging from novel formulations of approved peptides and proteins to immunoprotective scaffolds for cell therapies. Adocia's primary focus is on developing innovative formulations of insulins and other metabolic hormones, aiming to become a leading player in hormonal treatments.
Tags
Total Employees
90
Current headcount
Performance
Company Timeline
No timeline data for this period
Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Adocia do?
Adocia is a clinical-stage biotechnology company specializing in the development of innovative treatments for diabetes and obesity. They leverage disruptive technologies to create products ranging from novel formulations of approved peptides and proteins to immunoprotective scaffolds for cell therapies. Adocia's primary focus is on developing innovative formulations of insulins and other metabolic hormones, aiming to become a leading player in hormonal treatments.
Where is Adocia headquartered?
Adocia is headquartered in Lyon, France.
When was Adocia founded?
Adocia was founded in 2005.
What industry does Adocia operate in?
Adocia operates in Biotechnology, Pharmaceuticals, Healthcare.
How many employees does Adocia have?
Adocia has approximately 90 people on record.